IPSEN BIOPHARM LIMITED (01653765) is a private limited company registered in WREXHAM, incorporated in 1982. The company operates in the manufacture of basic pharmaceutical products sector. Our database holds 92 signals from 14 official sources covering this company's filings, appointments, and regulatory records. Risk assessment: 90/100 ("robust"), reflecting a strong compliance and financial profile.
Ipsen Biopharm Limited (01653765) is an active private limited company incorporated in 1982, situated in Wrexham, involved in the manufacture of basic
Good data coverage from 14 sources. Risk score of 90 indicates a strong compliance profile.
IPSEN BIOPHARM LIMITED is 1 of 4 manufacture of basic pharmaceutical products companies in WREXHAM, out of 1,164 active companies in this sector nationally (1,305 including dissolved).
The 3 directors of IPSEN BIOPHARM LIMITED are connected to 6 other companies.
None of these connected companies have been dissolved.
IPSEN BIOPHARM LIMITED is listed as the proprietor of 7 properties in the HM Land Registry.
Properties are located in South East, Wales.
IPSEN BIOPHARM LIMITED has received 1 Innovate UK grant.
IPSEN BIOPHARM LIMITED pays invoices in an average of 28 days. 67% are paid within 30 days.
IPSEN BIOPHARM LIMITED has been mentioned in 2 London or Edinburgh Gazette notices.
Gazette notices are official public records that may relate to company changes, winding-up petitions, or other statutory notifications.
This company profile is built from 13 official data sources: Ch Officers, Companies House, Environment Agency, GLEIF, Gateway to Research, Gender Pay Gap Service, HM Land Registry, HMRC Trade Info, ICO, Innovate UK, Modern Slavery Registry, Payment Practices, The Gazette.
Ipsen Biopharm Limited (01653765) is an active private limited company incorporated in 1982, situated in Wrexham, involved in the manufacture of basic.
Current directors include DR JOHN ANDREW CHADDOCK, , and 2 more.
IPSEN BIOPHARM LIMITED is registered in WREXHAM, United Kingdom.
IPSEN BIOPHARM LIMITED operates under SIC code 21100 — Manufacture of basic pharmaceutical products.
IPSEN BIOPHARM LIMITED has a risk score of 90 out of 100, classified as "Robust". This score is calculated from 92 data signals across 14 government sources.
The next accounts for IPSEN BIOPHARM LIMITED are due on 30 Sept 2026.
Yes, IPSEN BIOPHARM LIMITED is listed as the proprietor of 7 properties in the HM Land Registry, located in South East, Wales.
The dissolution rate for the manufacture of basic pharmaceutical products sector in the UK is 0.2%. The average company age in this sector is 13.6 years.
IPSEN BIOPHARM LIMITED is currently listed as "Active" on Companies House, indicating it is still a registered company. An "Active" status means the company has not been dissolved, struck off, or entered into liquidation.
IPSEN BIOPHARM LIMITED is registered as a Private Limited Company, which is a company limited by shares whose shares are not offered to the general public. It is the most common type of UK company, offering limited liability to its shareholders.
IPSEN BIOPHARM LIMITED was incorporated on 23 Jul 1982, making it 44 years old. The company remains active and in good standing.
IPSEN BIOPHARM LIMITED is classified under SIC code 21100 (Manufacture of basic pharmaceutical products). The Standard Industrial Classification system is used by the UK government to categorise businesses by their primary economic activity.
We track 92 data signals from 14 official government sources for IPSEN BIOPHARM LIMITED.